What is the Share Price of Lincoln Pharmaceuticals Ltd?
- Answer Field
-
The share price of Lincoln Pharmaceuticals Ltd for NSE is ₹ 592 and for BSE is ₹ 589.8.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, LINCOLN PHARMA LTD share price is currently at ₹ 592, which is down by ₹ -7.75 from its previous closing. Today, the stock has fluctuated between ₹ 577.55 and ₹ 604.85. Over the past year, LINCOLN PHARMA LTD has achieved a return of -0.92 %. In the last month alone, the return has been 10.59 %. Read More...
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others.
The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.
The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project.
The Company launched Next Generation Progesterone Therapy 'ProlinSpray' during the year 2018.
During the year 2021-22, Lincoln Parenteral Limited, an erstwhile subsidiary, merged with the Company through Scheme of Amalgamation and Lincoln Parenteral Limited ceased to be a subsidiary of the Company.
The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.
The share price of Lincoln Pharmaceuticals Ltd for NSE is ₹ 592 and for BSE is ₹ 589.8.
The market cap of Lincoln Pharmaceuticals Ltd for NSE is ₹ 11,88.20 Cr. and for BSE is ₹ 0.0 Cr. as of now.
The 52 Week High and Low of Lincoln Pharmaceuticals Ltd for NSE is ₹ 979.50 and ₹ 499.00 and for BSE is ₹ 975.00 and ₹ 498.00.
You can trade in Lincoln Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 1.08%.
Lincoln Pharmaceuticals Ltd share price is for NSE ₹ 592 & for BSE ₹ 589.8 as on Apr 25 2025 03:29 PM.
The market cap of Lincoln Pharmaceuticals Ltd for NSE ₹ 11,88.20 & for BSE ₹ 0.0 as on Apr 25 2025 03:29 PM.
As on Apr 25 2025 03:29 PM the price-to-earnings (PE) ratio for Lincoln Pharmaceuticals Ltd share is 13.44.
As on Apr 25 2025 03:29 PM, the price-to-book (PB) ratio for Lincoln Pharmaceuticals Ltd share is 319.15.
You can trade in Lincoln Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Lincoln Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Lincoln Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found